Celgene Corporation Overview
Company Headquarters: New Jersey, US
Founded: 1986
Workforce: 8,852
Company Working:
Celgene Corporation is a global leading biopharmaceutical company focused on the development and commercialization of innovative drugs used in the treatment of cancer and inflammatory diseases. The company conducted more than 300 clinical trials for various applications such as multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), triple-negative breast cancer, and pancreatic cancer. It has a strong presence in North America, Europe, and Asia.
Strategy
Celgene Corporation focuses on developing a diversified product portfolio by the innovation and development of products, thus delivering integrated solutions to large healthcare customers. It also emphasizes acquisitions and collaborations to enhance its presence in the industry.



